or Try an Advanced Search...

    Technical Analysis for XLO - Xilio Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.92 -2.49% -0.02
    XLO closed down 2.49 percent on Monday, July 1, 2024, on 36 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical XLO trend table...
    Date Alert Name Type % Chg
    Up 3 Days in a Row Strength -2.49%
    Outside Day Range Expansion -1.71%
    NR7 Range Contraction 1.29%
    Inside Day Range Contraction 1.29%
    Gapped Up Strength 1.29%
    180 Bearish Setup Bearish Swing Setup 2.64%
    Inside Day Range Contraction 2.64%
    BB Squeeze Ended Range Expansion -0.74%
    Lower Bollinger Band Touch Weakness -0.74%
    Bollinger Band Squeeze Range Contraction 1.71%
    Older End-of-Day Signals for XLO ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 6 hours ago
    Down 5% about 6 hours ago
    10 DMA Support about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    10 DMA Resistance about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    XLO Chart by TradingView
    Basic chart:

    Profile

    Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Immunotherapy Tumor Cancer Immunotherapy Immunotherapies Immune Checkpoint Checkpoint Inhibitor Tumor Microenvironment

    Is XLO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 13 Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
    May 29 Gilead and Cartography enter deal to develop cancer therapies
    May 14 Xilio Therapeutics GAAP EPS of -$0.62
    May 14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
    Apr 16 Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
    Apr 1 Xilio Therapeutics reports Q4 results
    Apr 1 Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
    Apr 1 Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Mar 28 Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results
    Mar 28 Xilio stock jumps on Gilead Sciences license deal
    See more XLO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.9379
    52 Week Low 0.49
    Average Volume 330,319
    200-Day Moving Average 1.15
    50-Day Moving Average 1.06
    20-Day Moving Average 0.99
    10-Day Moving Average 0.93
    Average True Range 0.09
    RSI (14) 41.86
    ADX 16.49
    +DI 13.97
    -DI 19.48
    Chandelier Exit (Long, 3 ATRs) 0.88
    Chandelier Exit (Short, 3 ATRs) 1.11
    Upper Bollinger Bands 1.12
    Lower Bollinger Band 0.86
    Percent B (%b) 0.24
    BandWidth 26.43
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram -0.0032
    Fundamentals Value
    Market Cap 25.43 Million
    Num Shares 27.5 Million
    EPS -2.96
    Price-to-Earnings (P/E) Ratio -0.31
    Price-to-Sales 0.00
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.02
    Resistance 3 (R3) 1.02 0.99 1.00
    Resistance 2 (R2) 0.99 0.97 0.99 1.00
    Resistance 1 (R1) 0.96 0.95 0.94 0.96 0.99
    Pivot Point 0.93 0.93 0.92 0.93 0.93
    Support 1 (S1) 0.89 0.90 0.88 0.89 0.86
    Support 2 (S2) 0.86 0.89 0.86 0.85
    Support 3 (S3) 0.83 0.86 0.85
    Support 4 (S4) 0.83